Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M91.3Revenue $M3.5Net Margin (%)-1,004.2Altman Z-Score-18.2
Enterprise Value $M59.4EPS $-0.6Operating Margin %-1,268.3Piotroski F-Score2
P/E(ttm)9,999Beneish M-Score-4.2Pre-tax Margin (%)-1,004.2Higher ROA y-yY
Price/Book5.010-y EBITDA Growth Rate %-38.0Quick Ratio2.2Cash flow > EarningsN
Price/Sales30.35-y EBITDA Growth Rate %-21.9Current Ratio2.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-74.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-258.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M73.0ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SNSS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNSSFirst Eagle Investment 2015-06-30 Sold Out $2.07 - $3.01
($2.53)
$ 1.21-52%Sold Out0
SNSSFirst Eagle Investment 2015-03-31 Reduce-0.01%$2.1 - $2.83
($2.4)
$ 1.21-50%Reduce 58.43%587,976
SNSSFirst Eagle Investment 2014-12-31 Buy 0.01%$1.05 - $6.64
($2.06)
$ 1.21-41%New holding1,414,276
SNSSFirst Eagle Investment 2014-09-30 Sold Out $5.553 - $8.23
($6.91)
$ 1.21-82%Sold Out0
SNSSFirst Eagle Investment 2013-09-30 Buy $4.55 - $6.05
($5.08)
$ 1.21-76%New holding200,000
SNSSFirst Eagle Investment 2013-03-31 Sold Out -0.01%$4 - $6.49
($5.21)
$ 1.21-77%Sold Out0
SNSSFirst Eagle Investment 2012-09-30 Reduce$2.95 - $5.76
($3.55)
$ 1.21-66%Reduce 30.24%350,000
SNSSFirst Eagle Investment 2012-06-30 Buy 0.01%$2.51 - $3.18
($2.78)
$ 1.21-56%New holding501,727
SNSSFirst Eagle Investment 2009-12-31 Sold Out $1.8 - $12.54
($3.76)
$ 1.21-68%Sold Out0
SNSSFirst Eagle Investment 2009-06-30 Reduce$0.99 - $3.45
($1.95)
$ 1.21-38%Reduce 90.60%16,667
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNSS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SNSS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Swisher Daniel N JRPresident and CEO 2015-08-25Buy25,000$1.0119.8view
Ketchum Steven BDirector 2015-07-24Sell6,358$3.46-65.03view
BJERKHOLT ERICEVP, CFO & Corp. Secretary 2015-07-24Sell6,358$3.46-65.03view
Swisher Daniel N JRPresident and CEO 2015-07-24Sell12,715$3.46-65.03view
BAY CITY CAPITAL LLC10% Owner 2015-07-24Sell635,702$3.46-65.03view
BARRIS PETER J10% Owner 2014-08-29Sell266,700$7.97-84.82view
BARRETT M JAMES10% Owner 2014-08-29Sell266,700$7.97-84.82view
Growth Equity Opportunities Fu10% Owner 2014-08-29Sell266,700$7.97-84.82view
SANDELL SCOTT D10% Owner 2014-08-29Sell266,700$7.97-84.82view
KOLLURI KRISHNA KITTU10% Owner 2014-08-29Sell266,700$7.97-84.82view

Quarterly/Annual Reports about SNSS:

News about SNSS:

Articles On GuruFocus.com
ciazek stock Mar 28 2015 
comment on SNSS Mar 02 2013 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
Weekly CFO Buys Highlight: SNSS, INUV, CEP, CMTL, SURW Oct 09 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 13 2010 
cooldecency99 note on SNSS May 01 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Apr 29 2010 
Hardest Hit Companies of the Day: Transition Therapeutics Inc., Sunesis Pharmaceuticals Inc., GenCor Dec 15 2009 
Most Trade Guru Stocks: Citigroup Inc., Bank of America Corp., Alcoa Inc., Sunesis Pharmaceuticals Dec 12 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 16 2009 

More From Other Websites
4 Biotech Stocks Under $10 to Trade for Breakouts Aug 11 2015
IBB claws its way back Aug 10 2015
SUNESIS PHARMACEUTICALS INC Financials Aug 06 2015
Sunesis Pharmaceuticals to Present at the 2015 Wedbush PacGrow Healthcare Conference Aug 05 2015
Sunesis Announces Publication of Vosaroxin Phase 3 VALOR Trial Results in The Lancet Oncology Aug 04 2015
10-Q for Sunesis Pharmaceuticals, Inc. Aug 01 2015
SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 30 2015
Sunesis reports 2Q loss Jul 30 2015
Sunesis reports 2Q loss Jul 30 2015
Sunesis Pharmaceuticals Reports Second Quarter 2015 Financial Results and Recent Highlights Jul 30 2015
Sunesis Pharmaceuticals (SNSS) Jumps: Stock Gains 9.5% - Tale of the Tape Jul 28 2015
GPM Announces Investigation of Sunesis Pharmaceuticals, Inc. Jul 27 2015
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against Sunesis... Jul 24 2015
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against Sunesis... Jul 24 2015
Investigation of Sunesis Pharmaceuticals, Inc. Announced by The Law Offices of Howard G. Smith Jul 24 2015
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Sunesis Pharmaceuticals, Inc.... Jul 24 2015
Shareholder Alert: AF&T Announces That It Has Been Retained to Investigate Claims on Behalf of... Jul 24 2015
Is This the End of Sunesis? Jul 24 2015
Top Analyst Upgrades and Downgrades: Amazon, GM, SolarCity, Sunesis, United Continental, Disney,... Jul 24 2015
Sunesis Pharma downgraded by ROTH Capital and Cantor Fitzgerald Jul 24 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK